Myelosuppresion + GI toxicity Flashcards
(81 cards)
What conditions do myelosuppresion entail (3)
- Low neutrophils -> neutropenia
- Low RBCs -> Anemia
- Low platelets -> Thrombocytopenia
Treatments that cause myelosuppression
- Radiation
- Cytotoxic chemotherapy
- Monoclonal antibodies
- Targeted agents
Treatments that can cause myelosuppresion
- Radiation
- Cytotoxic chemo
- Monoclonal antibodies
- targeted agents
Why is cancer therapy myelosuppressive in these classes
Cytotoxic chemotherapy
Targeted agents
Anti-CD20
Cytotoxic chemotherapy
- directly destroys dividng stem cells
Targeted agents
- Interfere with cellular signaling that is part of hematopoiesis
Anti-CD20
- cause deletion of B-cells
Which myelosuppression was the most common DOSE-limiting toxicity associated with chemotherapy
Neutropenia
What are risk factors for neutropenia and its complications
Type of chemo
- Cytotoxic chemo is most common. Also with some targeted agents (CDK4/6, BTK inhibitors)
- Most BREAST cancer regimens, many HEME cancer regimens and CHEMORADIOTHERAPY for LUNG cancer have high risk of neutropenia
Initial cycle (if it doesn’t happen in the first, wont happen)
Older age
Female sex
Baseline status: WBC count, performance status
Dysfunction: hepatic, renal
What grade of neutropenia would you intervene in and lower dose
Grade 3 or 4
Define febrile neutropenia? Cause?
Defined as a fever for at least an hour and in the setting of neutropenia
- infectious cause
When to treat febrile neutropenia
What to use normally
for low risk
MRSA risk
Treat when they have fever + under the LLN of neutrophils
What to use normally
- Treat empirically with broad spectrum antibiotics
- Piptaz, carbapenem, ceftazidime
for low risk
- manage as outpatient with Ciprofloxacin + Cephalosporin
MRSA risk
- add vanco
What drug class is given as prophylaxis? when is it given?
G-CSF
(Granulocyte colony stimulating factors)
(filgrastim, pegfilgrastim)
- boosts WBC count
- only give when its curative intent
What risk assessment do you do when giving prophylaxis for FN
Disease type
Chemo regimen
Patient risk factors
Neutropenia with previous cycle
Treatment intent (has to be curative)
Differentiate between Filgrastim and pegfilgrastim
Dose
Start
ADRs (3)
Filgrastim
- DAILY SC 24-72 hrs after for 7-10 days
pegfilgrastim
- ONCE SC 24 hours after chemo
ADRs
- bone pain (large bones like skull, femer, spine)
- Injection site reactions
- Anaphylaxis
What are the benefits of GCSF prophylaxis
They cause the NADIR (10-14 days after dose where neutrophils are the lowest) to occur EARLIER and LESS SEVERELY
- Result is an EARLIER and BETTER recovery from the neutropenic state
What patient risk factors are intermediate that you would consider GCSF
- prior chemo or radiation
- Persistent neutropenia
- Bone marrow involvement by tumour
- Recent surgery
- Liver dysfunction
- Renal dysfunction
- Age 65+ receiving full chemo dose intensity
What are other preventative measure of febrile neutropenia
- Frequent hand washing. Especially around Nadir period
- Hand sanitize frequent
- Avoid crowded conditions, people with contagious conditions (colds, etc.)
If patient develops fever of >38C lasting >1 hour OR >38.3C at any time -> contact hospital IMMEDIATELY
How does cancer treatment cause anemia? (5)
- Chemo/radiation
- Anemia of cancer (chronic disease) (impaired erythropoietin production/response, impaired iron re-utilization)
- Blood loss
- Nutritional deficiency
- Hemolysis
What are risk factors for cancer-related anemia
- Tumour type
- Stage and duration of disease
- regimen and intensity of tumour therapy (platinum agents known for anemia)
- Presence of infection
- Surgical intervention
What are symptoms of anemia in cancer patients?
Which one is the greatest?
FATIGUE, dizziness, depression
Anorexia, Nausea
Low skin temp, pallor skin
Increased tachy, palipiation
T/F Anemia Fatigue is relieved by sleep or rest in cancer patients
False
What hgb levels does fatigue increase significantly in
<120 hgb
When are RBC transfusions indicated in anemia (2)
- Rapid correction of Hb
- Increase in blood volume
What are drawbacks of using RBC transfusion
- The effect of RBC transfusion are short lived
- It does not address the underlying process of anemia
- There are risks associated with RBC transfusion
What are the ADRs of RBC transfusion
Serious (4)
Mild (2)
Serious ADRs
- Transmission of infection (viral, HIV, hepatitis, bacterial)
- Acute and delayed hemolytic reactions
- Immunosuppression
- Transfuion-related acute lung injury
Mild
- Fever
- urticaria